Compare RNST & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNST | PLSE |
|---|---|---|
| Founded | 1904 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.3B |
| IPO Year | 1997 | 2015 |
| Metric | RNST | PLSE |
|---|---|---|
| Price | $41.22 | $48.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $43.00 | $22.00 |
| AVG Volume (30 Days) | ★ 518.9K | 386.7K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.88 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.72 | $840.00 |
| Revenue Next Year | $4.67 | $287.54 |
| P/E Ratio | $21.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.04 | $12.56 |
| 52 Week High | $44.54 | $50.90 |
| Indicator | RNST | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 38.01 | 65.48 |
| Support Level | $40.85 | $24.27 |
| Resistance Level | $41.88 | N/A |
| Average True Range (ATR) | 0.78 | 2.87 |
| MACD | -0.21 | -0.26 |
| Stochastic Oscillator | 25.82 | 62.63 |
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.